1. Home
  2. EPIX vs PNI Comparison

EPIX vs PNI Comparison

Compare EPIX & PNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPIX
  • PNI
  • Stock Information
  • Founded
  • EPIX 2009
  • PNI 2002
  • Country
  • EPIX Canada
  • PNI United States
  • Employees
  • EPIX N/A
  • PNI N/A
  • Industry
  • EPIX Biotechnology: Pharmaceutical Preparations
  • PNI Trusts Except Educational Religious and Charitable
  • Sector
  • EPIX Health Care
  • PNI Finance
  • Exchange
  • EPIX Nasdaq
  • PNI Nasdaq
  • Market Cap
  • EPIX 75.9M
  • PNI 75.2M
  • IPO Year
  • EPIX N/A
  • PNI N/A
  • Fundamental
  • Price
  • EPIX $1.93
  • PNI $6.50
  • Analyst Decision
  • EPIX Hold
  • PNI
  • Analyst Count
  • EPIX 3
  • PNI 0
  • Target Price
  • EPIX $2.00
  • PNI N/A
  • AVG Volume (30 Days)
  • EPIX 304.7K
  • PNI 26.4K
  • Earning Date
  • EPIX 08-13-2025
  • PNI 01-01-0001
  • Dividend Yield
  • EPIX N/A
  • PNI 4.76%
  • EPS Growth
  • EPIX N/A
  • PNI N/A
  • EPS
  • EPIX N/A
  • PNI N/A
  • Revenue
  • EPIX N/A
  • PNI N/A
  • Revenue This Year
  • EPIX N/A
  • PNI N/A
  • Revenue Next Year
  • EPIX N/A
  • PNI N/A
  • P/E Ratio
  • EPIX N/A
  • PNI N/A
  • Revenue Growth
  • EPIX N/A
  • PNI N/A
  • 52 Week Low
  • EPIX $1.40
  • PNI $6.03
  • 52 Week High
  • EPIX $7.88
  • PNI $7.89
  • Technical
  • Relative Strength Index (RSI)
  • EPIX 71.19
  • PNI 42.11
  • Support Level
  • EPIX $1.90
  • PNI $6.49
  • Resistance Level
  • EPIX $1.93
  • PNI $6.55
  • Average True Range (ATR)
  • EPIX 0.01
  • PNI 0.08
  • MACD
  • EPIX -0.00
  • PNI 0.00
  • Stochastic Oscillator
  • EPIX 100.00
  • PNI 18.92

About EPIX ESSA Pharma Inc.

ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.

About PNI Pimco New York Municipal Income Fund II of Beneficial Interest

PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.

Share on Social Networks: